Clinical Trial Update: Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC [Phase 2]

View source ↗

Summary

Phase IIa trial evaluating safety, pharmacokinetics, and tolerability of sodium nitrite in patients with peripheral arterial disease; results completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• sodium nitrite (sodium nitrite)

Snippet

Sponsor: TheraVasc Inc. | Conditions: Peripheral Arterial Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-07-01